CVAT — Cavitation Technologies Income Statement
0.000.00%
Last trade - 00:00- $2.56m
- $2.53m
- $0.43m
Annual income statement for Cavitation Technologies, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.09 | 1.66 | 0.558 | 1.67 | 0.433 |
| Cost of Revenue | |||||
| Gross Profit | 1.02 | 1.62 | 0.538 | 1.62 | 0.312 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.81 | 1.53 | 1.2 | 1.86 | 1.32 |
| Operating Profit | -0.723 | 0.136 | -0.643 | -0.195 | -0.886 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.723 | 0.128 | -0.649 | -0.619 | -2.04 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.723 | 0.128 | -0.649 | -0.619 | -2.04 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.723 | 0.128 | -0.649 | -0.619 | -2.04 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.723 | 0.128 | -0.649 | -0.619 | -2.04 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.004 | 0.001 | -0.004 | -0.002 | -0.007 |